RecruitingNCT07220824

A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting

GUselkumab for the Treatment of PsA: Effectiveness Results by Ultrasound

Sponsor

Janssen Research & Development, LLC

Enrollment

200 participants

Start Date

Dec 4, 2025

Study Type

OBSERVATIONAL

Conditions

Arthritis, Psoriatic

Summary

The purpose of this study is to assess how well guselkumab works in improving symptoms of psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches) using muscoloskeletal ultrasound (MSUS) in a real-world setting.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with arthritis, psoriatic. The study is currently recruiting participants at 21 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(21)

Policlinico di Bari

Bari, Italy

ASST Spedali Civili Brescia

Brescia, Italy

Hospital Carlo Urbani

Iesi, Italy

IRCCS Ospedale Galeazzi Sant Ambrogio

Milan, Italy

Istituto Ortopedico Gaetano Pini

Milan, Italy

San Raffaele Hospital

Milan, Italy

ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy

Azienda Ospedaliera Universitaria Federico II

Naples, Italy

Seconda Univesità degli Studi di Napoli, AOU

Naples, Italy

Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone

Palermo, Italy

Fondazione IRCCS Policlinico San Matteo

Pavia, Italy

Universita degli Studi di Perugia

Perugia, Italy

Ospedale Santa Chiara AO Universitaria Pisana

Pisa, Italy

Ospedale San Carlo Di Potenza - Azienda Ospedaliera Regionale

Potenza, Italy

Arcispedale Santa Maria Nuova - IRCCS

Reggio Emilia, Italy

Policlinico Di Tor Vergata

Roma, Italy

Fondazione Policlinico Universitario A Gemelli IRCCS

Roma, Italy

A O Universitaria Senese Ospedale Santa Maria alle Scotte

Siena, Italy

AO Ordine Mauriziano

Torino, Italy

ASST dei Sette Laghi, Ospedale di Circolo e Fonazione Macchi

Varese, Italy

Azienda Ospedaliera Universitaria Integrata Verona

Verona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07220824

Related Trials

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

NCT06641089139 locations

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

NCT0714100410 locations

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

NCT06807424224 locations

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

NCT0666333247 locations

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

NCT0732187372 locations